SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-20-255650
Filing Date
2020-09-28
Accepted
2020-09-28 09:15:59
Documents
1
Effectiveness Date
2020-09-28

Document Format Files

Seq Description Document Type Size
1 S-8 POS d77477ds8pos.htm S-8 POS 19615
  Complete submission text file 0001193125-20-255650.txt   20617
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-237063 | Film No.: 201202287
SIC: 2834 Pharmaceutical Preparations